Viewing Study NCT00436397



Ignite Creation Date: 2024-05-05 @ 5:21 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00436397
Status: COMPLETED
Last Update Posted: 2010-02-12
First Post: 2007-02-15

Brief Title: A New Radiation Therapy Planning System in Patients Undergoing Radiation Therapy for Cancer
Sponsor: Fox Chase Cancer Center
Organization: Fox Chase Cancer Center

Study Overview

Official Title: Evaluation of the Radionics Body Localizer System and XPLANIMRT for Extra-Cranial Sites A Pilot Study
Status: COMPLETED
Status Verified Date: 2010-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: RATIONALE A new radiation therapy planning system may help doctors plan better treatment for patients with cancer

PURPOSE This clinical trial is studying a new radiation therapy planning system in patients undergoing radiation therapy for extracranial cancer
Detailed Description: OBJECTIVES

Determine the ability of the Radionics Body System to immobilize and re-localize patients receiving radiotherapy to extra-cranial sites of cancer
Determine the accuracy of radiation dose calculations for extra-cranial sites of cancer when using the XPLAN-intensity modulated radiation therapy XPLANIMRT integrated software in this system

OUTLINE Patients receiving radiotherapy have a Body Localizer cast constructed and undergo a CT scan while immobilized in the Body Localizer Patients undergo another CT scan in the treatment position using the standard alpha cradle The XPLAN-intensity modulated radiation therapy XPLANIMRT-generated treatment plan is compared to the standard treatment plan to verify that the calculated dose is within 2-3 percent of the planned dose using standard technique Patients undergo sets of CT scans 3 additional times over the next few weeks for a total of 8 CT scans Patients may undergo additional CT scans before and after radiotherapy treatments for a maximum of 5 CT scans per week performed over the course of radiotherapy

PROJECTED ACCRUAL Approximately 60 patients will be accrued for this study

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
P30CA006927 NIH None None
FCCC-02604 US NIH GrantContract None httpsreporternihgovquickSearchP30CA006927